OverviewThe global viral vector manufacturing market is projected to expand at a robust CAGR of approximately 20% over the forecast period, supported by multiple transformative forces reshaping the ...

The US has issued a Level-2 travel advisory for Bangladesh amid a surge in chikungunya cases. CDC urges travelers to take ...

Ajinomoto launches CELLiST AAV Production Supplement 1, boosting gene therapy viral vector productivity by 1.3-2x.

The University of Oxford has commenced the world’s first Phase II clinical trial of a Nipah virus vaccine candidate in ...

ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today ...

The trial, conducted in Bangladesh in partnership with the International Centre for Diarrhoeal Disease Research, Bangladesh ...

The treatment uses a modified, harmless virus to deliver healthy genes to a patient’s cells to treat genetic diseases. Read ...

Epilepsygtx Ltd. has raised a $33 million series A to fund a phase I/IIa trial of EPY-201, a gene therapy for treating ...

ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic(R) technology has been licensed by Ginkgo ...

Mosquito and tick-borne diseases may become rampant in the South Bay as the Santa Clara County Vector Control District faces ...

Rise in mosquito density is a clear indication that dengue cases can spike any time, say senior Health officials ...